Pain News and Research

Latest Pain News and Research

Study describes first known case of necrotizing fasciitis from bath salts

A study led by Russell R. Russo, MD, a third-year Orthopaedic Surgery resident at LSU Health Sciences Center New Orleans School of Medicine, has identified a new source of life-threatening necrotizing fasciitis - "bath salts."

13 Jan 2012

Researchers discover previously unknown effect of opioids

A team of researchers at the MedUni Vienna's Department of Neurophysiology has discovered a previously unknown effect of opioids: the study, which has now been published in the highly respected magazine "Science" and was led by Ruth Drdla-Schutting and Jürgen Sandkühler, shows that opioids not only temporarily relieve pain, but at the right dose can also erase memory traces of pain in the spinal cord and therefore eliminate a key cause of chronic pain.

13 Jan 2012

CrystalGenomics raises KRW 3 billion in private placement

CrystalGenomics, Inc., a clinical stage biopharmaceutical company headquartered in Korea, has just announced that it has successfully raised KRW 3 Billion (USD 2.6 Million) in a private placement to the Korea Seoul Life Science Fund.

13 Jan 2012

Kedem commences development of Gleevec to treat CML in children and adults

Kedem Pharmaceuticals Inc., a specialty pharmaceutical company with focus on sublingual drug delivery system is pleased to announce that has initiated the development of Gleevec.

12 Jan 2012

Sangart commences MP4CO Phase 1b study in sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced the initiation of a Phase 1b study designed to evaluate the safety of MP4CO treatment in patients with sickle cell disease.

12 Jan 2012

Risk of sudden cardiac arrest while running a marathon is low in the healthy: Study

There have been reports of a marathoner collapsing suddenly with no pulse. Now a large study finds such calamities are rare and usually due to a pre-existing heart problem. The study also found such incidents are increasing as more runners try to go the distance.

12 Jan 2012

Scientists discover how sense of touch is wired in skin and nervous system

Neuroscientists at the Johns Hopkins University School of Medicine have discovered how the sense of touch is wired in the skin and nervous system. The new findings, published Dec. 22 in Cell, open new doors for understanding how the brain collects and processes information from hairy skin.

12 Jan 2012

Exposure to light appears to have therapeutic effects on Alzheimer's patients

Exposure to light appears to have therapeutic effects on Alzheimer's disease patients, a Wayne State University researcher has found.

12 Jan 2012

$Patients with hip fractures should be operated on within 48 hours of admission$

Patients with hip fractures should be operated on within 48 hours of admission

All patients with hip fractures should be fast-tracked through hospital emergency departments and operated on within 48 hours of admission, according to new consensus guidelines developed by UK experts in anaesthesia, orthopaedics, geriatrics and emergency medicine and published in the January issue of Anaesthesia.

12 Jan 2012

Omega-3 can protect nerves from injury and help them to regenerate

Research from Queen Mary, University of London suggests that omega-3 fatty acids, which are found in fish oil, have the potential to protect nerves from injury and help them to regenerate.

12 Jan 2012

Occasional marijuana use does not affect lung function: Study

A new study published in the Journal of the American Medical Association has shown that an occasional drag on marijuana does not appear to have long-term adverse effects on lung function.

11 Jan 2012

Damon Runyon Cancer Research Foundation names 18 new Fellows

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named 18 new Damon Runyon Fellows at its fall Fellowship Award Committee review.

11 Jan 2012

HealthSaaS enters innovative alliance with iMPak for chronic pain management and medication adherence

The iMPak Health Journal for Pain empowers patients to easily record their pain levels before and after their prescribed medication regimen, providing physicians with readily available, useful, patient information.

11 Jan 2012

Tobacco more harmful to lungs than marijuana

A large-scale national study suggests low to moderate use of marijuana is less harmful to users' lungs than exposure to tobacco, even though the two substances contain many of the same components. This comprehensive study, led by UCSF and University of Alabama at Birmingham, collected data from more than 5,000 U.S. adults for more than 20 years.

11 Jan 2012

India on verge of recording polio-free year

If India does not record a new polio case through January 13, "produc[ing] 12 straight months of polio-free surveillance data, it will be removed from the list of countries where polio is considered endemic, leaving only the other three," Pakistan, Afghanistan, and Nigeria, Scientific American reports.

11 Jan 2012

Baro-Therapies introduces portable barometric therapy device for pain, inflammation

Baro-Therapies, Inc. has announced the national launch of The Rejuvenator, a portable barometric therapy device that provides drug-free relief from inflammatory pain and neurological conditions using elevated barometric pressure.

11 Jan 2012

Shire, Janssen enter development and marketing agreement for Resolor

Shire plc, the global specialty biopharmaceutical company, announced today that it has acquired the rights to develop and market Resolor (prucalopride) in the United States (US) in an agreement with Janssen Pharmaceutica N.V.

11 Jan 2012

Shire acquires rights to develop and market Resolor in the U.S.

10 Jan 2012

Telormedix raises 7.5 million CHF

Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer and inflammatory diseases, today announced that it has raised 7.5 Million CHF from existing investors Aravis Venture and Proquest Investments.

10 Jan 2012

'ConTxt' study to evaluate whether cell phone technology can help with weight loss

Cell phones aren't just for talking any more. Surfing the web, storing music and posting to Facebook have all contributed to the near-mandatory use of a cell phone. How about using that cell phone to lose weight? Researchers with Calit2's Center for Wireless and Population Health Systems (CWPHS) and the Department of Family and Preventive Medicine, at University of California, San Diego are expanding a previous study aimed at finding out if cell phone technology can help with weight loss.

10 Jan 2012